Nucleus

Developed by Director of Medicinal Chemistry Mark Smith, the new method could make it possible for chemotherapy patients to take pills rather than receive IV infusions.

A promising novel drug candidate, designed at the atomic level, could help doctors halt the rise of lethal new drug resistant SARS-CoV-2 variants.

Scientists at Stanford and NYU have published and investigated a new structure of the protein LAG-3 which could enable the development of new cancer treatments.

Through c-ShARP, Stanford researchers get access to top-notch scientific facilities across campus, including the Sarafan ChEM-H Knowledge Centers.

A new study found that part of the Epstein-Barr virus mimics a protein made in the brain and spinal cord, leading the immune system to mistakenly attack the body’s nerve cells.

Researchers at Stanford are working to develop a single-dose vaccine for SARS-CoV-2 that could potentially be stored at room temperature.

Chemistry Professor Carolyn Bertozzi says recruiting world-class scientists and engineers and developing ChEM-H into a hub where doctors and researchers can come together.

Researchers are pursuing antiviral drugs with broad efficacy against enteroviruses, which cause common colds and polio, and coronaviruses including the one that causes COVID

Stanford’s new IMA arose before the COVID-19 pandemic struck, but now its programs are focused entirely on helping faculty generate and test new medicines to slow the spread.

An effort to thwart viral diseases like hepatitis or the common cold led to a new collaboration and a novel class of cancer drugs that appears effective in mice.

Immunotherapy has great promise as a cancer treatment, but current therapies only work in some. Researchers found that microorganisms in our guts might be the deciding factor.

Justin Annes, MD, PhD, assistant professor of endocrinology, gerontology and metabolism, feels that he owes a great deal of credit for his unique research program to the ChEM-H

By delivering a drug directly to beta cells, researchers may be able to spur insulin production and potentially develop a diabetes therapy in the future.

To treat diabetes directly, doctors need a way to get drugs to cells that produce insulin. The key, Stanford researchers report, may be those cells’ affinity for zinc.

Tracing the genetic process through which parakeets produce either yellow or blue feathers has given Stanford scientists insights that could uncover other biochemical pathways.

Physician-scientist Justin Annes specializes in a rare type of tumor disorders. He shares his story, and interests, in this Stars of Stanford Medicine Q&A.